The Korean Journal of Pain

The Korean Pain Society (대한통증학회)
권호 표지
DOI QR코드

DOI QR Code

Epidural Infusion of Morphine and Levobupivacaine through a Subcutaneous Port for Cancer Pain Management

  • Heo, Bong Ha (Department of Anesthesiology and Pain Medicine, Chonnam National University Medical School) ;
  • Pyeon, Tae Hee (Department of Anesthesiology and Pain Medicine, Chonnam National University Medical School) ;
  • Lee, Hyung Gon (Department of Anesthesiology and Pain Medicine, Chonnam National University Medical School) ;
  • Kim, Woong Mo (Department of Anesthesiology and Pain Medicine, Chonnam National University Medical School) ;
  • Choi, Jeong Il (Department of Anesthesiology and Pain Medicine, Chonnam National University Medical School) ;
  • Yoon, Myung Ha (Department of Anesthesiology and Pain Medicine, Chonnam National University Medical School)
  • Received : 2013.12.11
  • Accepted : 2014.02.19
  • Published : 2014.04.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: To manage intractable cancer pain, an alternative to systemic analgesics is neuraxial analgesia. In long-term treatment, intrathecal administration could provide a more satisfactory pain relief with lower doses of analgesics and fewer side-effects than that of epidural administration. However, implantable drug delivery systems using intrathecal pumps in Korea are very expensive. Considering cost-effectiveness, we performed epidural analgesia as an alternative to intrathecal analgesia. Methods: We retrospectively investigated the efficacy, side effects, and complications of epidural morphine and local anesthetic administration through epidural catheters connected to a subcutaneous injection port in 29 Korean terminal cancer patients. Patient demographic data, the duration of epidural administration, preoperative numerical pain rating scales (NRS), side effects and complications related to the epidural catheterization and the drugs, and the numerical pain rating scales on the 1st, 3rd, 7th and 30th postoperative days were determined from the medical records. Results: The average score for the numerical pain rating scales for the 29 patients decreased from $7{\pm}1.0$ at baseline to $3.6{\pm}1.4$ on postoperative day 1 (P < 0.001). A similar decrease in pain intensity was maintained for 30 days (P < 0.001). Nausea and vomiting were the most frequently reported side effects of the epidural analgesia and two patients (6.9%) experienced paresthesia. Conclusions: Epidural morphine and local anesthetic infusion with a subcutaneous pump seems to have an acceptable risk-benefit ratio and allows a high degree of autonomy to patients with cancer pain.

Keywords

References

  1. Nordberg G. Epidural versus intrathecal route of opioid administration. Int Anesthesiol Clin 1986; 24: 93-111.
  2. Morgan M. The rational use of intrathecal and extradural opioids. Br J Anaesth 1989; 63: 165-88. https://doi.org/10.1093/bja/63.2.165
  3. Nitescu P, Appelgren L, Linder LE, Sjoberg M, Hultman E, Curelaru I. Epidural versus intrathecal morphine-bupivacaine: assessment of consecutive treatments in advanced cancer pain. J Pain Symptom Manage 1990; 5: 18-26. https://doi.org/10.1016/S0885-3924(05)80005-3
  4. Crul BJ, Delhaas EM. Technical complications during long-term subarachnoid or epidural administration of morphine in terminally ill cancer patients: a review of 140 cases. Reg Anesth 1991; 16: 209-13.
  5. Kim JH, Jung JY, Cho MS. Continuous intrathecal morphine administration for cancer pain management using an intrathecal catheter connected to a subcutaneous injection port: a retrospective analysis of 22 terminal cancer patients in Korean population. Korean J Pain 2013; 26: 32-8. https://doi.org/10.3344/kjp.2013.26.1.32
  6. Aldrete JA. Intrathecal opioid infusions. Anesthesiology 2004; 101: 256. https://doi.org/10.1097/00000542-200407000-00043
  7. Krames ES. Intraspinal opioid therapy for chronic nonmalignant pain: current practice and clinical guidelines. J Pain Symptom Manage 1996; 11: 333-52. https://doi.org/10.1016/0885-3924(96)00010-3
  8. Nitescu P, Sjoberg M, Appelgren L, Curelaru I. Complications of intrathecal opioids and bupivacaine in the treatment of "refractory" cancer pain. Clin J Pain 1995; 11: 45-62. https://doi.org/10.1097/00002508-199503000-00006
  9. McClellan KJ, Spencer CM. Levobupivacaine. Drugs 1998; 56: 355-62. https://doi.org/10.2165/00003495-199856030-00005
  10. Ross VH, Pan PH, Owen MD, Seid MH, Harris L, Clyne B, et al. Neostigmine decreases bupivacaine use by patientcontrolled epidural analgesia during labor: a randomized controlled study. Anesth Analg 2009; 109: 524-31. https://doi.org/10.1213/ane.0b013e31819518e4
  11. Du Pen SL, Peterson DG, Williams A, Bogosian AJ. Infection during chronic epidural catheterization: diagnosis and treatment. Anesthesiology 1990; 73: 905-9. https://doi.org/10.1097/00000542-199011000-00018
  12. Smitt PS, Tsafka A, Teng-van de Zande F, van der Holt R, Elswijk-de Vries I, Elfrink E, et al. Outcome and complications of epidural analgesia in patients with chronic cancer pain. Cancer 1998; 83: 2015-22. https://doi.org/10.1002/(SICI)1097-0142(19981101)83:9<2015::AID-CNCR19>3.0.CO;2-R
  13. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991; 338: 339-43. https://doi.org/10.1016/0140-6736(91)90479-9
  14. De Cicco M, Matovic M, Castellani GT, Basaglia G, Santini G, Del Pup C, et al. Time-dependent efficacy of bacterial filters and infection risk in long-term epidural catheterization. Anesthesiology 1995; 82: 765-71. https://doi.org/10.1097/00000542-199503000-00019
  15. Waghorn DJ. Intravascular device-associated systemic infections: a 2 year analysis of cases in a district general hospital. J Hosp Infect 1994; 28: 91-101. https://doi.org/10.1016/0195-6701(94)90136-8
  16. de Jong PC, Kansen PJ. A comparison of epidural catheters with or without subcutaneous injection ports for treatment of cancer pain. Anesth Analg 1994; 78: 94-100.
  17. Carde P, Cosset-Delaigue MF, Laplanche A, Chareau I. Classical external indwelling central venous catheter versus totally implanted venous access systems for chemotherapy administration: a randomized trial in 100 patients with solid tumors. Eur J Cancer Clin Oncol 1989; 25: 939-44. https://doi.org/10.1016/0277-5379(89)90151-X
  18. Orser B. Obstetrical epidural anaesthesia in a Canadian outpost hospital. Can J Anaesth 1988; 35: 503-6. https://doi.org/10.1007/BF03026900
  19. Prince G, McGregor D. Obstetric epidural test doses. A reappraisal. Anaesthesia 1986; 41: 1240-50. https://doi.org/10.1111/j.1365-2044.1986.tb13011.x
  20. Guay J. The epidural test dose: a review. Anesth Analg 2006; 102: 921-9. https://doi.org/10.1213/01.ane.0000196687.88590.6b
  21. de Leon-Casasola OA. Interventional procedures for cancer pain management: when are they indicated? Cancer Invest 2004; 22: 630-42. https://doi.org/10.1081/CNV-200027166
  22. Bedder MD, Burchiel K, Larson A. Cost analysis of two implantable narcotic delivery systems. J Pain Symptom Manage 1991; 6: 368-73. https://doi.org/10.1016/0885-3924(91)90028-3
  23. Harney D, Victor R. Traumatic syrinx after implantation of an intrathecal catheter. Reg Anesth Pain Med 2004; 29: 606-9. https://doi.org/10.1097/00115550-200411000-00015
  24. Schimpf J, Krakow K, Vehreschild N, Pohlmann-Eden B. Transverse myelopathy as a complication following long-term intrathecal application of morphine in chronic back pain. Anasthesiol Intensivmed Notfallmed Schmerzther 1999; 34: 506-9. https://doi.org/10.1055/s-1999-199

Cited by

  1. Anatomic Variations of Cervical and High Thoracic Ligamentum Flavum vol.27, pp.4, 2014, https://doi.org/10.3344/kjp.2014.27.4.321
  2. Continuous Cervical Epidural Analgesia in Metastatic Spinal Cord Compression vol.22, pp.4, 2014, https://doi.org/10.4103/0973-1075.191860